Action Needed to Improve Timeliness and Enhance Scope of FDA's Debarment and Disqualification Processes for Medical Product Investigators

Crosse, Marcia
October 2009
GAO Reports;10/22/2009, preceding p1
Government Document
The article reports on the study conducted by the U.S. Government Accountability Office (GAO) on the action needed to improve the Food and Drug Administration's (FDA) timely completion of debarment and disqualification processes clinical investigators. It states that investigators who have engaged in wrongful conduct such as presenting fraudulent data can be debarred or disqualified. GAO recommends that the FDA commissioner should ensure the timely completion of the proceedings.


Related Articles

  • Two men sentenced for assaulting inspector. Farley, Dixie // FDA Consumer;Jun96, Vol. 30 Issue 5, p34 

    Reports on the case concerning the assault of an employee of the US Food & Drug Administration. Sentencing of two officials of a New York food warehouse; Details of the investigation.

  • Real-life courage. Goode, Erica // U.S. News & World Report;12/09/96, Vol. 121 Issue 23, p11 

    Opinion. Explains why Dr. David Kessler is a modern-day hero as he announces his resignation as commissioner of the US Food and Drug Administration (FDA). His stance against the tobacco industry; His love for Harper Lee's novel `To Kill a Mockingbird.'

  • FDA vets leave. Conlan, Michael F. // Drug Topics;1/5/98, Vol. 142 Issue 1, p19 

    Presents information on United States Food and Drug Administration employees who have resigned. Identification of some of the employees who resigned.

  • Two vie for job as the FDA's top cop. Dickinson, James G. // Medical Marketing & Media;Jul98, Vol. 33 Issue 7, p31 

    States that two employees of the United States Food and Drug Administration are competing for the position of associate commissioner for regulatory affairs. Names and positions of the employees; Who will the winner succeed.

  • FDA's walking encyclopedias. Adams, Betsy; Henkel, John // FDA Consumer;May95, Vol. 29 Issue 4, p22 

    Discusses the functions of FDA's public affairs specialists (PAS). Conducting workshops and seminars to organizations about FDA's work; Assisting reporters in news story development; Educational and training background of PAS. INSET: How to contact a public affairs specialist, by J.H..

  • Focus on pediatric exclusivity clause and preventing drug abuse. Foxhall, Kathryn // Contemporary Pediatrics;Jul2007, Vol. 24 Issue 7, p18 

    This article reports on the need for continuing current laws that encourage and sometimes mandate the testing of drugs for use in children, according to a representative from the U.S. Food and Drug Administration at a Congressional hearing. The May 2007 hearing came as the House of...

  • NATIONAL CORD BLOOD INVENTORY: Practices for Increasing Availability for Transplants and Related Challenges.  // GAO Reports;10/7/2011, preceding p1 

    The article presents a report from the U.S. Government Accountability Office (GAO) regarding the inventory of national cord blood. It notes that the agency has examined practices that will increase the banking of cord blood units while examining the ways using efficient cord blood banking....

  • No Token Appointment. Davis, Don // Global Cosmetic Industry;Mar2002, Vol. 170 Issue 3, p46 

    Focuses on the importance of the U.S. Food and Drug Administration commissioner in the U.S. Comments on the little accumulation of support from such important presidential appointment; Possible changes on the philosophy of cosmetic from whoever will head the FDA; Frustrations of some marketers...

  • Turning a disability into an opportunity.  // Hispanic Times Magazine;Mar/Apr1991, Vol. 12 Issue 2, p10 

    Profiles Irene Gomez, a Mexican American employee at the Food and Drug Administration. Position as Food and Drug Inspector; Accident that necessitated Gomez's undergoing back surgery; Incapacity that led to Gomez's reassignment to the Public Affairs Department.


Read the Article

Other Topics